ACP-501 (rhLCAT)

recombinant human lecithin-cholesterol acyltransferase

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACP-501 (rhLCAT), covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)